Stay updated on M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe webpage has removed significant background information about pancreatic cancer and the investigational drug M7824, while adding a new version number and a reference to a study location.SummaryDifference42%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check79 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check100 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page.